Corinna Galli Selected Research

1,4-3,6-dianhydromannitol

1/2021

NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corinna Galli Research Topics

Disease

2	Ocular Hypertension (Glaucoma, Suspect) 01/2021 - 01/2021
2	Malaria 01/2016 - 01/2015
1	Reperfusion Injury 01/2022
1	Ischemia 01/2022
1	Glaucoma 01/2021
1	Infections 01/2015

Drug/Important Bio-Agent (IBA)

2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2021
2	plasmepsin (plasmepsin I)IBA 01/2016 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2015
1	Endothelin-1 (Endothelin 1)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021
1	avanafilIBA 01/2021
1	1,4-3,6-dianhydromannitolIBA 01/2021
1	EnzymesIBA 01/2015

Therapy/Procedure

1	Lasers (Laser) 01/2021